Abstract:Adult-onset Still's disease (AOSD) is a rare disease affecting multiple systems and organs with unknown etiology, and the clinical symptoms are usually described as spiking fever, arthritis, evanescent salmon-pink eruptions, lymphadenopathy, splenomegaly, and other manifestations. The laboratory indicators are not specific, often presenting as increased leukocyte counts and neutrophil percentage, elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), hyperferritinemia, and increased inflammatory factors. ANA, ENA, and RF are negative. According to those unspecific clinical presentations and laboratory findings, infection, tumor, connective tissue disease, and other diseases must be ruled out before diagnosis. The diagnosis of AOSD is a great challenge for clinicians. The mechanism of AOSD pathogenesis is complicated and still being studied. There is a new opinion that atypical persistent skin eruptions (APSEs) with specific histological manifestations are unique for AOSD, and APSEs might be on a spectrum with classical evanescent eruptions. Studies on APSEs showed that IL-1 beta and IFN-gamma are strongly correlated with the pathogenesis of necrosis keratinocytes in APSEs. IL-1 beta is strongly involved in inflammatory disease when it is abnormal, and plays an important role in the pathogenesis of neutrophil dermatosis. In the early stage of AOSD, skin lesions appear to be evanescent urticaria-like eruptions accompanied by fever, and only neutrophils infiltrate around the blood vessels in the dermis pathologically. As the course of the disease progresses, IL-1 beta is gradually released. Through the stimulation of other inflammatory factors and the influence of unknown factors, IL-1 beta gradually infiltrates into the stratum corneum and finally accumulates around the necrotic keratinocytes of the stratum corneum. However, the detailed mechanism is still unknown. IFN-gamma could play a pro-inflammatory or regulatory role in some disorders. IL-1 beta can enhance the expression of IFN-gamma, and IFN-gamma can cause keratinocyte apoptosis by activating the autocrine of caspase. Also, several pieces of evidence indicate that adaptive immunity is also involved in the pathogenesis of AOSD. Increased alpha-soluble receptors of IL-2 may suggest T-cell activation and proliferation in AOSD patients. Increased IL-4- and IFN-gamma-producing T cells were found in active AOSD and related to disease severity. Frequencies of Treg cells in AOSD were significantly lower and were inversely correlated with disease severity. According to these, more and more researchers have reached a consensus that AOSD is a disease at the crossroads of innate immunity and autoimmunity. In this review, we will provide a comprehensive insight into AOSD, describing research progress and the immunological mechanism contribution to the disease. In the meantime, different treatment options and the efficacy and safety of various biologic agents are also discussed. A further understanding of AOSD requires closer cooperation among doctors from different departments, and this review will provide a new idea for diagnosis and therapeutic options.

Genetic Association and Expression Correlation between Colony-Stimulating Factor 1 Gene Encoding M-CSF and Adult-Onset Still's Disease

Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still’s Disease

A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease

Clinical Characteristics and Outcome of Elderly Onset Adult-Onset Still?s Disease: A 10-Year Retrospective Study

Both HLA Class I and II Regions Identified As Genome-Wide Significant Susceptibility Loci for Adult-Onset Still's Disease in Chinese Individuals

Characterization of genetic landscape and novel inflammatory biomarkers in patients with adult‐onset Still's disease

Macrophage migration inhibitory factor promoter polymorphisms and predisposition to adult onset Still's disease in Chinese population

The Association of ATG16L1 Variations with Clinical Phenotypes of Adult-Onset Still’s Disease

The Landscape of Innate and Adaptive Immune Cell Subsets in Patients with Adult-Onset Still's Disease

Genetic and Pharmacological Targeting of GSDMD Ameliorates Systemic Inflammation in Macrophage Activation Syndrome

Identification of novel cytokine to judge the diagnosis and clinical phenotype of adult-onset Still's disease

The amino acid variants in HLA II molecules explain the major association with adult-onset Still's disease in the Han Chinese population

Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options

Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease

The Levels of Macrophage Migration Inhibitory Factor As an Indicator of Disease Activity and Severity in Adult-Onset Still's Disease.

Adult-onset Still's Disease: A Disease at the Crossroad of Innate Immunity and Autoimmunity

Clinical Phenotypes and Prognostic Factors of Adult-Onset Still’s Disease: Data from a Large Inpatient Cohort

Prognostic factors for adult-onset Still disease: a retrospective analysis of 90 patients in China

Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's disease

Clinical and immunological feature, therapeutic response and prognosis of adult onset Still's disease

Clinical characteristics of patients with macrophage activation syndrome secondary to adult-onset Still's disease